Candidature YC de Rhizome AI
Rhizome AI a été sélectionné par Y Combinator dans le cadre du batch Winter 2026 en tant qu'entreprise B2B. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.
- Batch YC
- Winter 2026
- Secteur d'activité
- B2B
- Taille de l'équipe
- 1
- Statut
- Active
- Lancé
- 2026
Fondateurs
Chetan MishraFounder
Ce que fait Rhizome AI
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Candidature YC de Rhizome AI, reconstruite
Candidature Y Combinator
Rhizome AI, promotion Winter 2026. Les vraies questions de candidature, répondues à partir de données publiques.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Rhizome AI
Agent Platform for Life Sciences
We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.
I live in New York City and the company is based there and remotely distributed.
New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.
21 réponses supplémentaires dans la candidature complète
se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.
Questions fréquemment posées
Est-ce la vraie candidature YC de Rhizome AI ?
Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Rhizome AI (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Rhizome AI se présenterait à YC, pas le texte qu'ils ont soumis.
À quel batch YC Rhizome AI appartenait-il ?
Rhizome AI faisait partie du batch Winter 2026 de Y Combinator.
Qui a fondé Rhizome AI ?
Rhizome AI a été fondé par Chetan Mishra.
Que fait Rhizome AI ?
Agent Platform for Life Sciences
Comment lire la candidature complète reconstruite ?
Créez un compte Round Funded gratuit. La version complète de la candidature de Rhizome AI en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.
Plus de startups YC comme Rhizome AI
